| Affiliation: | 1. Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK;2. Porter Neuroscience Research Center, NINDS, NIH, Bethesda MD, United States;1. Institute of Biology, Cellular Biophysics, Humboldt Universität zu Berlin, 10115 Berlin, Germany;2. Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany;3. Cluster of Excellence NeuroCure, Charité Universitätsmedizin, 10117 Berlin, Germany;1. Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan;2. Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK;1. Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA;1. Molecular Physiology and Biophysics Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland;1. Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA;2. Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY 10065, USA |
